Protara Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Protara Therapeutics, Inc. (Nasdaq: TARA) announced participation in two virtual fireside chats at upcoming healthcare conferences. The Cowen 42nd Annual Health Care Conference is scheduled for March 9, 2022, at 9:10 am ET, followed by the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, at 2:00 pm ET. Interested parties can access the live webcasts on Protara's website, where they will remain archived for 90 days. Protara focuses on innovative therapies for cancer and rare diseases, including its lead program TARA-002.

NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in fireside chats at two upcoming virtual conferences:

• Cowen 42nd Annual Health Care Conference on March 9, 2022 at 9:10am ET
• Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022 at 2:00pm ET

A live webcast of the fireside chats can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcasts will be archived on the Company’s website for 90 days following the presentations.

About Protara Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

What is Protara Therapeutics participating in on March 9, 2022?

Protara Therapeutics will participate in the Cowen 42nd Annual Health Care Conference on March 9, 2022, at 9:10 am ET.

When is Protara's presentation at the Oppenheimer Healthcare Conference?

Protara will present at the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, at 2:00 pm ET.

How can I access the webcasts of Protara's presentations?

The webcasts can be accessed through the Events and Presentations section of Protara's website.

What is TARA-002 developed by Protara Therapeutics?

TARA-002 is an investigational cell-based therapy being developed for non-muscle invasive bladder cancer and lymphatic malformations.